BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pistono C, Osera C, Boiocchi C, Mallucci G, Cuccia M, Bergamaschi R, Pascale A. What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question. Pharmacol Res 2017;120:279-93. [PMID: 28396093 DOI: 10.1016/j.phrs.2017.03.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Prinz C, Starke L, Millward JM, Fillmer A, Delgado PR, Waiczies H, Pohlmann A, Rothe M, Nazaré M, Paul F, Niendorf T, Waiczies S. In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy. Theranostics 2021;11:2490-504. [PMID: 33456555 DOI: 10.7150/thno.47130] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Zanghì A, D'Amico E, Patti F. Immunosuppression in relapsing remitting multiple sclerosis: moving towards personalized treatment. Expert Rev Neurother 2020;20:771-82. [PMID: 31971026 DOI: 10.1080/14737175.2020.1721282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pistono C, Monti MC, Boiocchi C, Berzolari FG, Osera C, Mallucci G, Cuccia M, Pascale A, Montomoli C, Bergamaschi R. Response to oxidative stress of peripheral blood mononuclear cells from multiple sclerosis patients and healthy controls. Cell Stress Chaperones 2020;25:81-91. [PMID: 31720998 DOI: 10.1007/s12192-019-01049-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F. Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment. Mol Neurobiol 2020;57:1245-58. [PMID: 31721043 DOI: 10.1007/s12035-019-01792-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
5 Maltby VE, Lea RA, Graves MC, Sanders KA, Benton MC, Tajouri L, Scott RJ, Lechner-Scott J. Genome-wide DNA methylation changes in CD19+ B cells from relapsing-remitting multiple sclerosis patients. Sci Rep 2018;8:17418. [PMID: 30479356 DOI: 10.1038/s41598-018-35603-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
6 Maltby VE, Lea RA, Ribbons KA, Sanders KA, Kennedy D, Min M, Scott RJ, Lechner-Scott J. DNA methylation changes in CD4+ T cells isolated from multiple sclerosis patients on dimethyl fumarate. Mult Scler J Exp Transl Clin 2018;4:2055217318787826. [PMID: 30038789 DOI: 10.1177/2055217318787826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]